Cargando…

A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update

BACKGROUND: We previously reported that the incidence of hepatocellular carcinoma (HCC) with non-viral etiologies increased rapidly between 1991 and 2010 in Japan. METHODS: To update this investigation, we enrolled patients who were initially diagnosed as having non-B, non-C HCC at participating hos...

Descripción completa

Detalles Bibliográficos
Autores principales: Tateishi, Ryosuke, Uchino, Koji, Fujiwara, Naoto, Takehara, Tetsuo, Okanoue, Takeshi, Seike, Masataka, Yoshiji, Hitoshi, Yatsuhashi, Hiroshi, Shimizu, Masahito, Torimura, Takuji, Moriyama, Mitsuhiko, Sakaida, Isao, Okada, Hiroyuki, Chiba, Tetsuhiro, Chuma, Makoto, Nakao, Kazuhiko, Isomoto, Hajime, Sasaki, Yutaka, Kaneko, Shuichi, Masaki, Tsutomu, Chayama, Kazuaki, Koike, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437291/
https://www.ncbi.nlm.nih.gov/pubmed/30498904
http://dx.doi.org/10.1007/s00535-018-1532-5
_version_ 1783406934717628416
author Tateishi, Ryosuke
Uchino, Koji
Fujiwara, Naoto
Takehara, Tetsuo
Okanoue, Takeshi
Seike, Masataka
Yoshiji, Hitoshi
Yatsuhashi, Hiroshi
Shimizu, Masahito
Torimura, Takuji
Moriyama, Mitsuhiko
Sakaida, Isao
Okada, Hiroyuki
Chiba, Tetsuhiro
Chuma, Makoto
Nakao, Kazuhiko
Isomoto, Hajime
Sasaki, Yutaka
Kaneko, Shuichi
Masaki, Tsutomu
Chayama, Kazuaki
Koike, Kazuhiko
author_facet Tateishi, Ryosuke
Uchino, Koji
Fujiwara, Naoto
Takehara, Tetsuo
Okanoue, Takeshi
Seike, Masataka
Yoshiji, Hitoshi
Yatsuhashi, Hiroshi
Shimizu, Masahito
Torimura, Takuji
Moriyama, Mitsuhiko
Sakaida, Isao
Okada, Hiroyuki
Chiba, Tetsuhiro
Chuma, Makoto
Nakao, Kazuhiko
Isomoto, Hajime
Sasaki, Yutaka
Kaneko, Shuichi
Masaki, Tsutomu
Chayama, Kazuaki
Koike, Kazuhiko
author_sort Tateishi, Ryosuke
collection PubMed
description BACKGROUND: We previously reported that the incidence of hepatocellular carcinoma (HCC) with non-viral etiologies increased rapidly between 1991 and 2010 in Japan. METHODS: To update this investigation, we enrolled patients who were initially diagnosed as having non-B, non-C HCC at participating hospitals between 2011 and 2015. In addition to the patient characteristics investigated in the previous report, we also investigated the duration of alcohol consumption. The overall survival rate was analyzed using the Kaplan–Meier method, and the hazard function against the body mass index (BMI) was plotted using cubic splines. RESULTS: A total of 2087 patients were enrolled. The proportion of patients with non-viral etiologies has continued to increase from 10.0% in 1991 to 32.5% in 2015. Patients were also older (median ages, 70–73 years) and more obese (median BMIs, 23.9–24.2 kg/m(2)), and the proportions of patients with diabetes mellitus (46.1% to 51.6%), hypertension (42.7% to 58.6%), dyslipidemia (14.6% to 22.9%), and fatty liver (24.0% to 28.8%) had all increased significantly. There was a significant inverse relationship between the duration and the amount of daily alcohol consumption. The improvement in the overall survival was relatively small, with a decreased proportion of patients under surveillance (41.3% to 31.6%). A hazard function plot showed a curve similar to that in our previous report, with a lowest hazard of ~ 26 kg/m(2). CONCLUSIONS: The proportion of HCC patients with non-viral etiologies continues to increase in Japan. Lifetime total amount of alcohol consumption may be a risk factor. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00535-018-1532-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6437291
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-64372912019-04-15 A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update Tateishi, Ryosuke Uchino, Koji Fujiwara, Naoto Takehara, Tetsuo Okanoue, Takeshi Seike, Masataka Yoshiji, Hitoshi Yatsuhashi, Hiroshi Shimizu, Masahito Torimura, Takuji Moriyama, Mitsuhiko Sakaida, Isao Okada, Hiroyuki Chiba, Tetsuhiro Chuma, Makoto Nakao, Kazuhiko Isomoto, Hajime Sasaki, Yutaka Kaneko, Shuichi Masaki, Tsutomu Chayama, Kazuaki Koike, Kazuhiko J Gastroenterol Original Article—Liver, Pancreas, and Biliary Tract BACKGROUND: We previously reported that the incidence of hepatocellular carcinoma (HCC) with non-viral etiologies increased rapidly between 1991 and 2010 in Japan. METHODS: To update this investigation, we enrolled patients who were initially diagnosed as having non-B, non-C HCC at participating hospitals between 2011 and 2015. In addition to the patient characteristics investigated in the previous report, we also investigated the duration of alcohol consumption. The overall survival rate was analyzed using the Kaplan–Meier method, and the hazard function against the body mass index (BMI) was plotted using cubic splines. RESULTS: A total of 2087 patients were enrolled. The proportion of patients with non-viral etiologies has continued to increase from 10.0% in 1991 to 32.5% in 2015. Patients were also older (median ages, 70–73 years) and more obese (median BMIs, 23.9–24.2 kg/m(2)), and the proportions of patients with diabetes mellitus (46.1% to 51.6%), hypertension (42.7% to 58.6%), dyslipidemia (14.6% to 22.9%), and fatty liver (24.0% to 28.8%) had all increased significantly. There was a significant inverse relationship between the duration and the amount of daily alcohol consumption. The improvement in the overall survival was relatively small, with a decreased proportion of patients under surveillance (41.3% to 31.6%). A hazard function plot showed a curve similar to that in our previous report, with a lowest hazard of ~ 26 kg/m(2). CONCLUSIONS: The proportion of HCC patients with non-viral etiologies continues to increase in Japan. Lifetime total amount of alcohol consumption may be a risk factor. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00535-018-1532-5) contains supplementary material, which is available to authorized users. Springer Japan 2018-11-29 2019 /pmc/articles/PMC6437291/ /pubmed/30498904 http://dx.doi.org/10.1007/s00535-018-1532-5 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article—Liver, Pancreas, and Biliary Tract
Tateishi, Ryosuke
Uchino, Koji
Fujiwara, Naoto
Takehara, Tetsuo
Okanoue, Takeshi
Seike, Masataka
Yoshiji, Hitoshi
Yatsuhashi, Hiroshi
Shimizu, Masahito
Torimura, Takuji
Moriyama, Mitsuhiko
Sakaida, Isao
Okada, Hiroyuki
Chiba, Tetsuhiro
Chuma, Makoto
Nakao, Kazuhiko
Isomoto, Hajime
Sasaki, Yutaka
Kaneko, Shuichi
Masaki, Tsutomu
Chayama, Kazuaki
Koike, Kazuhiko
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update
title A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update
title_full A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update
title_fullStr A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update
title_full_unstemmed A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update
title_short A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update
title_sort nationwide survey on non-b, non-c hepatocellular carcinoma in japan: 2011–2015 update
topic Original Article—Liver, Pancreas, and Biliary Tract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437291/
https://www.ncbi.nlm.nih.gov/pubmed/30498904
http://dx.doi.org/10.1007/s00535-018-1532-5
work_keys_str_mv AT tateishiryosuke anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT uchinokoji anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT fujiwaranaoto anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT takeharatetsuo anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT okanouetakeshi anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT seikemasataka anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT yoshijihitoshi anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT yatsuhashihiroshi anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT shimizumasahito anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT torimuratakuji anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT moriyamamitsuhiko anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT sakaidaisao anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT okadahiroyuki anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT chibatetsuhiro anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT chumamakoto anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT nakaokazuhiko anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT isomotohajime anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT sasakiyutaka anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT kanekoshuichi anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT masakitsutomu anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT chayamakazuaki anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT koikekazuhiko anationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT tateishiryosuke nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT uchinokoji nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT fujiwaranaoto nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT takeharatetsuo nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT okanouetakeshi nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT seikemasataka nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT yoshijihitoshi nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT yatsuhashihiroshi nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT shimizumasahito nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT torimuratakuji nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT moriyamamitsuhiko nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT sakaidaisao nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT okadahiroyuki nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT chibatetsuhiro nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT chumamakoto nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT nakaokazuhiko nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT isomotohajime nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT sasakiyutaka nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT kanekoshuichi nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT masakitsutomu nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT chayamakazuaki nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update
AT koikekazuhiko nationwidesurveyonnonbnonchepatocellularcarcinomainjapan20112015update